Pharma & Healthcare
Global DA2PP (DHPP) Vaccine Market Research Report 2026
- Feb 03, 26
- ID: 693114
- Pages: 123
- Figures: 123
- Views: 4
This report delivers a comprehensive overview of the global DA2PP (DHPP) Vaccine market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding DA2PP (DHPP) Vaccine. The DA2PP (DHPP) Vaccine market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global DA2PP (DHPP) Vaccine market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist DA2PP (DHPP) Vaccine manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Zoetis
Merck Animal Health
Pfizer
Boehringer Ingelheim
Virbac
Durvet
Elanco
RuiPu Bio-Technology
CAHIC
Wuhan Keqian Biology
Jilin Five-Star Animal Health
NeoTech
Segment by Type
Inactivated Vaccines
Live Attenuated Vaccines
by Application
Puppies
Adult Dogs
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for DA2PP (DHPP) Vaccine manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines DA2PP (DHPP) Vaccine sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
The report segments the global DA2PP (DHPP) Vaccine market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist DA2PP (DHPP) Vaccine manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Zoetis
Merck Animal Health
Pfizer
Boehringer Ingelheim
Virbac
Durvet
Elanco
RuiPu Bio-Technology
CAHIC
Wuhan Keqian Biology
Jilin Five-Star Animal Health
NeoTech
Segment by Type
Inactivated Vaccines
Live Attenuated Vaccines
by Application
Puppies
Adult Dogs
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for DA2PP (DHPP) Vaccine manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines DA2PP (DHPP) Vaccine sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
1 DA2PP (DHPP) Vaccine Market Overview
1.1 Product Definition
1.2 DA2PP (DHPP) Vaccine by Type
1.2.1 Global DA2PP (DHPP) Vaccine Market Value by Type: 2025 vs 2032
1.2.2 Inactivated Vaccines
1.2.3 Live Attenuated Vaccines
1.3 DA2PP (DHPP) Vaccine by Application
1.3.1 Global DA2PP (DHPP) Vaccine Market Value by Application: 2025 vs 2032
1.3.2 Puppies
1.3.3 Adult Dogs
1.4 Global DA2PP (DHPP) Vaccine Market Size Estimates and Forecasts
1.4.1 Global DA2PP (DHPP) Vaccine Revenue 2021–2032
1.4.2 Global DA2PP (DHPP) Vaccine Sales 2021–2032
1.4.3 Global DA2PP (DHPP) Vaccine Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 DA2PP (DHPP) Vaccine Market Competition by Manufacturers
2.1 Global DA2PP (DHPP) Vaccine Sales Market Share by Manufacturers (2021–2026)
2.2 Global DA2PP (DHPP) Vaccine Revenue Market Share by Manufacturers (2021–2026)
2.3 Global DA2PP (DHPP) Vaccine Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of DA2PP (DHPP) Vaccine, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of DA2PP (DHPP) Vaccine, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of DA2PP (DHPP) Vaccine, Product Types and Applications
2.7 Global Key Manufacturers of DA2PP (DHPP) Vaccine, Date of Entry into the Industry
2.8 Global DA2PP (DHPP) Vaccine Market Competitive Situation and Trends
2.8.1 Global DA2PP (DHPP) Vaccine Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global DA2PP (DHPP) Vaccine Players Market Share by Revenue
2.8.3 Global DA2PP (DHPP) Vaccine Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global DA2PP (DHPP) Vaccine Market Scenario by Region
3.1 Global DA2PP (DHPP) Vaccine Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global DA2PP (DHPP) Vaccine Sales by Region: 2021–2032
3.2.1 Global DA2PP (DHPP) Vaccine Sales by Region: 2021–2026
3.2.2 Global DA2PP (DHPP) Vaccine Sales by Region: 2027–2032
3.3 Global DA2PP (DHPP) Vaccine Revenue by Region: 2021–2032
3.3.1 Global DA2PP (DHPP) Vaccine Revenue by Region: 2021–2026
3.3.2 Global DA2PP (DHPP) Vaccine Revenue by Region: 2027–2032
3.4 North America DA2PP (DHPP) Vaccine Market Facts & Figures by Country
3.4.1 North America DA2PP (DHPP) Vaccine Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America DA2PP (DHPP) Vaccine Sales by Country (2021–2032)
3.4.3 North America DA2PP (DHPP) Vaccine Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe DA2PP (DHPP) Vaccine Market Facts & Figures by Country
3.5.1 Europe DA2PP (DHPP) Vaccine Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe DA2PP (DHPP) Vaccine Sales by Country (2021–2032)
3.5.3 Europe DA2PP (DHPP) Vaccine Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific DA2PP (DHPP) Vaccine Market Facts & Figures by Region
3.6.1 Asia Pacific DA2PP (DHPP) Vaccine Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific DA2PP (DHPP) Vaccine Sales by Region (2021–2032)
3.6.3 Asia Pacific DA2PP (DHPP) Vaccine Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America DA2PP (DHPP) Vaccine Market Facts & Figures by Country
3.7.1 Latin America DA2PP (DHPP) Vaccine Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America DA2PP (DHPP) Vaccine Sales by Country (2021–2032)
3.7.3 Latin America DA2PP (DHPP) Vaccine Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa DA2PP (DHPP) Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa DA2PP (DHPP) Vaccine Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa DA2PP (DHPP) Vaccine Sales by Country (2021–2032)
3.8.3 Middle East and Africa DA2PP (DHPP) Vaccine Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global DA2PP (DHPP) Vaccine Sales by Type (2021–2032)
4.1.1 Global DA2PP (DHPP) Vaccine Sales by Type (2021–2026)
4.1.2 Global DA2PP (DHPP) Vaccine Sales by Type (2027–2032)
4.1.3 Global DA2PP (DHPP) Vaccine Sales Market Share by Type (2021–2032)
4.2 Global DA2PP (DHPP) Vaccine Revenue by Type (2021–2032)
4.2.1 Global DA2PP (DHPP) Vaccine Revenue by Type (2021–2026)
4.2.2 Global DA2PP (DHPP) Vaccine Revenue by Type (2027–2032)
4.2.3 Global DA2PP (DHPP) Vaccine Revenue Market Share by Type (2021–2032)
4.3 Global DA2PP (DHPP) Vaccine Price by Type (2021–2032)
5 Segment by Application
5.1 Global DA2PP (DHPP) Vaccine Sales by Application (2021–2032)
5.1.1 Global DA2PP (DHPP) Vaccine Sales by Application (2021–2026)
5.1.2 Global DA2PP (DHPP) Vaccine Sales by Application (2027–2032)
5.1.3 Global DA2PP (DHPP) Vaccine Sales Market Share by Application (2021–2032)
5.2 Global DA2PP (DHPP) Vaccine Revenue by Application (2021–2032)
5.2.1 Global DA2PP (DHPP) Vaccine Revenue by Application (2021–2026)
5.2.2 Global DA2PP (DHPP) Vaccine Revenue by Application (2027–2032)
5.2.3 Global DA2PP (DHPP) Vaccine Revenue Market Share by Application (2021–2032)
5.3 Global DA2PP (DHPP) Vaccine Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Zoetis
6.1.1 Zoetis Company Information
6.1.2 Zoetis Description and Business Overview
6.1.3 Zoetis DA2PP (DHPP) Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Zoetis DA2PP (DHPP) Vaccine Product Portfolio
6.1.5 Zoetis Recent Developments/Updates
6.2 Merck Animal Health
6.2.1 Merck Animal Health Company Information
6.2.2 Merck Animal Health Description and Business Overview
6.2.3 Merck Animal Health DA2PP (DHPP) Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Merck Animal Health DA2PP (DHPP) Vaccine Product Portfolio
6.2.5 Merck Animal Health Recent Developments/Updates
6.3 Pfizer
6.3.1 Pfizer Company Information
6.3.2 Pfizer Description and Business Overview
6.3.3 Pfizer DA2PP (DHPP) Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Pfizer DA2PP (DHPP) Vaccine Product Portfolio
6.3.5 Pfizer Recent Developments/Updates
6.4 Boehringer Ingelheim
6.4.1 Boehringer Ingelheim Company Information
6.4.2 Boehringer Ingelheim Description and Business Overview
6.4.3 Boehringer Ingelheim DA2PP (DHPP) Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Boehringer Ingelheim DA2PP (DHPP) Vaccine Product Portfolio
6.4.5 Boehringer Ingelheim Recent Developments/Updates
6.5 Virbac
6.5.1 Virbac Company Information
6.5.2 Virbac Description and Business Overview
6.5.3 Virbac DA2PP (DHPP) Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Virbac DA2PP (DHPP) Vaccine Product Portfolio
6.5.5 Virbac Recent Developments/Updates
6.6 Durvet
6.6.1 Durvet Company Information
6.6.2 Durvet Description and Business Overview
6.6.3 Durvet DA2PP (DHPP) Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Durvet DA2PP (DHPP) Vaccine Product Portfolio
6.6.5 Durvet Recent Developments/Updates
6.7 Elanco
6.7.1 Elanco Company Information
6.7.2 Elanco Description and Business Overview
6.7.3 Elanco DA2PP (DHPP) Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Elanco DA2PP (DHPP) Vaccine Product Portfolio
6.7.5 Elanco Recent Developments/Updates
6.8 RuiPu Bio-Technology
6.8.1 RuiPu Bio-Technology Company Information
6.8.2 RuiPu Bio-Technology Description and Business Overview
6.8.3 RuiPu Bio-Technology DA2PP (DHPP) Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 RuiPu Bio-Technology DA2PP (DHPP) Vaccine Product Portfolio
6.8.5 RuiPu Bio-Technology Recent Developments/Updates
6.9 CAHIC
6.9.1 CAHIC Company Information
6.9.2 CAHIC Description and Business Overview
6.9.3 CAHIC DA2PP (DHPP) Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 CAHIC DA2PP (DHPP) Vaccine Product Portfolio
6.9.5 CAHIC Recent Developments/Updates
6.10 Wuhan Keqian Biology
6.10.1 Wuhan Keqian Biology Company Information
6.10.2 Wuhan Keqian Biology Description and Business Overview
6.10.3 Wuhan Keqian Biology DA2PP (DHPP) Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Wuhan Keqian Biology DA2PP (DHPP) Vaccine Product Portfolio
6.10.5 Wuhan Keqian Biology Recent Developments/Updates
6.11 Jilin Five-Star Animal Health
6.11.1 Jilin Five-Star Animal Health Company Information
6.11.2 Jilin Five-Star Animal Health Description and Business Overview
6.11.3 Jilin Five-Star Animal Health DA2PP (DHPP) Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Jilin Five-Star Animal Health DA2PP (DHPP) Vaccine Product Portfolio
6.11.5 Jilin Five-Star Animal Health Recent Developments/Updates
6.12 NeoTech
6.12.1 NeoTech Company Information
6.12.2 NeoTech Description and Business Overview
6.12.3 NeoTech DA2PP (DHPP) Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 NeoTech DA2PP (DHPP) Vaccine Product Portfolio
6.12.5 NeoTech Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 DA2PP (DHPP) Vaccine Industry Chain Analysis
7.2 DA2PP (DHPP) Vaccine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 DA2PP (DHPP) Vaccine Production Mode & Process Analysis
7.4 DA2PP (DHPP) Vaccine Sales and Marketing
7.4.1 DA2PP (DHPP) Vaccine Sales Channels
7.4.2 DA2PP (DHPP) Vaccine Distributors
7.5 DA2PP (DHPP) Vaccine Customer Analysis
8 DA2PP (DHPP) Vaccine Market Dynamics
8.1 DA2PP (DHPP) Vaccine Industry Trends
8.2 DA2PP (DHPP) Vaccine Market Drivers
8.3 DA2PP (DHPP) Vaccine Market Challenges
8.4 DA2PP (DHPP) Vaccine Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 DA2PP (DHPP) Vaccine by Type
1.2.1 Global DA2PP (DHPP) Vaccine Market Value by Type: 2025 vs 2032
1.2.2 Inactivated Vaccines
1.2.3 Live Attenuated Vaccines
1.3 DA2PP (DHPP) Vaccine by Application
1.3.1 Global DA2PP (DHPP) Vaccine Market Value by Application: 2025 vs 2032
1.3.2 Puppies
1.3.3 Adult Dogs
1.4 Global DA2PP (DHPP) Vaccine Market Size Estimates and Forecasts
1.4.1 Global DA2PP (DHPP) Vaccine Revenue 2021–2032
1.4.2 Global DA2PP (DHPP) Vaccine Sales 2021–2032
1.4.3 Global DA2PP (DHPP) Vaccine Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 DA2PP (DHPP) Vaccine Market Competition by Manufacturers
2.1 Global DA2PP (DHPP) Vaccine Sales Market Share by Manufacturers (2021–2026)
2.2 Global DA2PP (DHPP) Vaccine Revenue Market Share by Manufacturers (2021–2026)
2.3 Global DA2PP (DHPP) Vaccine Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of DA2PP (DHPP) Vaccine, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of DA2PP (DHPP) Vaccine, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of DA2PP (DHPP) Vaccine, Product Types and Applications
2.7 Global Key Manufacturers of DA2PP (DHPP) Vaccine, Date of Entry into the Industry
2.8 Global DA2PP (DHPP) Vaccine Market Competitive Situation and Trends
2.8.1 Global DA2PP (DHPP) Vaccine Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global DA2PP (DHPP) Vaccine Players Market Share by Revenue
2.8.3 Global DA2PP (DHPP) Vaccine Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global DA2PP (DHPP) Vaccine Market Scenario by Region
3.1 Global DA2PP (DHPP) Vaccine Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global DA2PP (DHPP) Vaccine Sales by Region: 2021–2032
3.2.1 Global DA2PP (DHPP) Vaccine Sales by Region: 2021–2026
3.2.2 Global DA2PP (DHPP) Vaccine Sales by Region: 2027–2032
3.3 Global DA2PP (DHPP) Vaccine Revenue by Region: 2021–2032
3.3.1 Global DA2PP (DHPP) Vaccine Revenue by Region: 2021–2026
3.3.2 Global DA2PP (DHPP) Vaccine Revenue by Region: 2027–2032
3.4 North America DA2PP (DHPP) Vaccine Market Facts & Figures by Country
3.4.1 North America DA2PP (DHPP) Vaccine Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America DA2PP (DHPP) Vaccine Sales by Country (2021–2032)
3.4.3 North America DA2PP (DHPP) Vaccine Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe DA2PP (DHPP) Vaccine Market Facts & Figures by Country
3.5.1 Europe DA2PP (DHPP) Vaccine Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe DA2PP (DHPP) Vaccine Sales by Country (2021–2032)
3.5.3 Europe DA2PP (DHPP) Vaccine Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific DA2PP (DHPP) Vaccine Market Facts & Figures by Region
3.6.1 Asia Pacific DA2PP (DHPP) Vaccine Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific DA2PP (DHPP) Vaccine Sales by Region (2021–2032)
3.6.3 Asia Pacific DA2PP (DHPP) Vaccine Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America DA2PP (DHPP) Vaccine Market Facts & Figures by Country
3.7.1 Latin America DA2PP (DHPP) Vaccine Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America DA2PP (DHPP) Vaccine Sales by Country (2021–2032)
3.7.3 Latin America DA2PP (DHPP) Vaccine Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa DA2PP (DHPP) Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa DA2PP (DHPP) Vaccine Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa DA2PP (DHPP) Vaccine Sales by Country (2021–2032)
3.8.3 Middle East and Africa DA2PP (DHPP) Vaccine Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global DA2PP (DHPP) Vaccine Sales by Type (2021–2032)
4.1.1 Global DA2PP (DHPP) Vaccine Sales by Type (2021–2026)
4.1.2 Global DA2PP (DHPP) Vaccine Sales by Type (2027–2032)
4.1.3 Global DA2PP (DHPP) Vaccine Sales Market Share by Type (2021–2032)
4.2 Global DA2PP (DHPP) Vaccine Revenue by Type (2021–2032)
4.2.1 Global DA2PP (DHPP) Vaccine Revenue by Type (2021–2026)
4.2.2 Global DA2PP (DHPP) Vaccine Revenue by Type (2027–2032)
4.2.3 Global DA2PP (DHPP) Vaccine Revenue Market Share by Type (2021–2032)
4.3 Global DA2PP (DHPP) Vaccine Price by Type (2021–2032)
5 Segment by Application
5.1 Global DA2PP (DHPP) Vaccine Sales by Application (2021–2032)
5.1.1 Global DA2PP (DHPP) Vaccine Sales by Application (2021–2026)
5.1.2 Global DA2PP (DHPP) Vaccine Sales by Application (2027–2032)
5.1.3 Global DA2PP (DHPP) Vaccine Sales Market Share by Application (2021–2032)
5.2 Global DA2PP (DHPP) Vaccine Revenue by Application (2021–2032)
5.2.1 Global DA2PP (DHPP) Vaccine Revenue by Application (2021–2026)
5.2.2 Global DA2PP (DHPP) Vaccine Revenue by Application (2027–2032)
5.2.3 Global DA2PP (DHPP) Vaccine Revenue Market Share by Application (2021–2032)
5.3 Global DA2PP (DHPP) Vaccine Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Zoetis
6.1.1 Zoetis Company Information
6.1.2 Zoetis Description and Business Overview
6.1.3 Zoetis DA2PP (DHPP) Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Zoetis DA2PP (DHPP) Vaccine Product Portfolio
6.1.5 Zoetis Recent Developments/Updates
6.2 Merck Animal Health
6.2.1 Merck Animal Health Company Information
6.2.2 Merck Animal Health Description and Business Overview
6.2.3 Merck Animal Health DA2PP (DHPP) Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Merck Animal Health DA2PP (DHPP) Vaccine Product Portfolio
6.2.5 Merck Animal Health Recent Developments/Updates
6.3 Pfizer
6.3.1 Pfizer Company Information
6.3.2 Pfizer Description and Business Overview
6.3.3 Pfizer DA2PP (DHPP) Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Pfizer DA2PP (DHPP) Vaccine Product Portfolio
6.3.5 Pfizer Recent Developments/Updates
6.4 Boehringer Ingelheim
6.4.1 Boehringer Ingelheim Company Information
6.4.2 Boehringer Ingelheim Description and Business Overview
6.4.3 Boehringer Ingelheim DA2PP (DHPP) Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Boehringer Ingelheim DA2PP (DHPP) Vaccine Product Portfolio
6.4.5 Boehringer Ingelheim Recent Developments/Updates
6.5 Virbac
6.5.1 Virbac Company Information
6.5.2 Virbac Description and Business Overview
6.5.3 Virbac DA2PP (DHPP) Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Virbac DA2PP (DHPP) Vaccine Product Portfolio
6.5.5 Virbac Recent Developments/Updates
6.6 Durvet
6.6.1 Durvet Company Information
6.6.2 Durvet Description and Business Overview
6.6.3 Durvet DA2PP (DHPP) Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Durvet DA2PP (DHPP) Vaccine Product Portfolio
6.6.5 Durvet Recent Developments/Updates
6.7 Elanco
6.7.1 Elanco Company Information
6.7.2 Elanco Description and Business Overview
6.7.3 Elanco DA2PP (DHPP) Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Elanco DA2PP (DHPP) Vaccine Product Portfolio
6.7.5 Elanco Recent Developments/Updates
6.8 RuiPu Bio-Technology
6.8.1 RuiPu Bio-Technology Company Information
6.8.2 RuiPu Bio-Technology Description and Business Overview
6.8.3 RuiPu Bio-Technology DA2PP (DHPP) Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 RuiPu Bio-Technology DA2PP (DHPP) Vaccine Product Portfolio
6.8.5 RuiPu Bio-Technology Recent Developments/Updates
6.9 CAHIC
6.9.1 CAHIC Company Information
6.9.2 CAHIC Description and Business Overview
6.9.3 CAHIC DA2PP (DHPP) Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 CAHIC DA2PP (DHPP) Vaccine Product Portfolio
6.9.5 CAHIC Recent Developments/Updates
6.10 Wuhan Keqian Biology
6.10.1 Wuhan Keqian Biology Company Information
6.10.2 Wuhan Keqian Biology Description and Business Overview
6.10.3 Wuhan Keqian Biology DA2PP (DHPP) Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Wuhan Keqian Biology DA2PP (DHPP) Vaccine Product Portfolio
6.10.5 Wuhan Keqian Biology Recent Developments/Updates
6.11 Jilin Five-Star Animal Health
6.11.1 Jilin Five-Star Animal Health Company Information
6.11.2 Jilin Five-Star Animal Health Description and Business Overview
6.11.3 Jilin Five-Star Animal Health DA2PP (DHPP) Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Jilin Five-Star Animal Health DA2PP (DHPP) Vaccine Product Portfolio
6.11.5 Jilin Five-Star Animal Health Recent Developments/Updates
6.12 NeoTech
6.12.1 NeoTech Company Information
6.12.2 NeoTech Description and Business Overview
6.12.3 NeoTech DA2PP (DHPP) Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 NeoTech DA2PP (DHPP) Vaccine Product Portfolio
6.12.5 NeoTech Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 DA2PP (DHPP) Vaccine Industry Chain Analysis
7.2 DA2PP (DHPP) Vaccine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 DA2PP (DHPP) Vaccine Production Mode & Process Analysis
7.4 DA2PP (DHPP) Vaccine Sales and Marketing
7.4.1 DA2PP (DHPP) Vaccine Sales Channels
7.4.2 DA2PP (DHPP) Vaccine Distributors
7.5 DA2PP (DHPP) Vaccine Customer Analysis
8 DA2PP (DHPP) Vaccine Market Dynamics
8.1 DA2PP (DHPP) Vaccine Industry Trends
8.2 DA2PP (DHPP) Vaccine Market Drivers
8.3 DA2PP (DHPP) Vaccine Market Challenges
8.4 DA2PP (DHPP) Vaccine Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global DA2PP (DHPP) Vaccine Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global DA2PP (DHPP) Vaccine Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global DA2PP (DHPP) Vaccine Market Competitive Situation by Manufacturers in 2025
Table 4. Global DA2PP (DHPP) Vaccine Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global DA2PP (DHPP) Vaccine Sales Market Share by Manufacturers (2021–2026)
Table 6. Global DA2PP (DHPP) Vaccine Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global DA2PP (DHPP) Vaccine Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market DA2PP (DHPP) Vaccine Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of DA2PP (DHPP) Vaccine, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of DA2PP (DHPP) Vaccine, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of DA2PP (DHPP) Vaccine, Product Types and Applications
Table 12. Global Key Manufacturers of DA2PP (DHPP) Vaccine, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global DA2PP (DHPP) Vaccine Companies by Tier (Tier 1, Tier 2, Tier 3), based on DA2PP (DHPP) Vaccine Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global DA2PP (DHPP) Vaccine Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global DA2PP (DHPP) Vaccine Sales by Region (K Units), 2021–2026
Table 18. Global DA2PP (DHPP) Vaccine Sales Market Share by Region (2021–2026)
Table 19. Global DA2PP (DHPP) Vaccine Sales by Region (K Units), 2027–2032
Table 20. Global DA2PP (DHPP) Vaccine Sales Market Share by Region (2027–2032)
Table 21. Global DA2PP (DHPP) Vaccine Revenue by Region (US$ Million), 2021–2026
Table 22. Global DA2PP (DHPP) Vaccine Revenue Market Share by Region (2021–2026)
Table 23. Global DA2PP (DHPP) Vaccine Revenue by Region (US$ Million), 2027–2032
Table 24. Global DA2PP (DHPP) Vaccine Revenue Market Share by Region (2027–2032)
Table 25. North America DA2PP (DHPP) Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America DA2PP (DHPP) Vaccine Sales by Country (K Units), 2021–2026
Table 27. North America DA2PP (DHPP) Vaccine Sales by Country (K Units), 2027–2032
Table 28. North America DA2PP (DHPP) Vaccine Revenue by Country (US$ Million), 2021–2026
Table 29. North America DA2PP (DHPP) Vaccine Revenue by Country (US$ Million), 2027–2032
Table 30. Europe DA2PP (DHPP) Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe DA2PP (DHPP) Vaccine Sales by Country (K Units), 2021–2026
Table 32. Europe DA2PP (DHPP) Vaccine Sales by Country (K Units), 2027–2032
Table 33. Europe DA2PP (DHPP) Vaccine Revenue by Country (US$ Million), 2021–2026
Table 34. Europe DA2PP (DHPP) Vaccine Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific DA2PP (DHPP) Vaccine Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific DA2PP (DHPP) Vaccine Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific DA2PP (DHPP) Vaccine Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific DA2PP (DHPP) Vaccine Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific DA2PP (DHPP) Vaccine Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America DA2PP (DHPP) Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America DA2PP (DHPP) Vaccine Sales by Country (K Units), 2021–2026
Table 42. Latin America DA2PP (DHPP) Vaccine Sales by Country (K Units), 2027–2032
Table 43. Latin America DA2PP (DHPP) Vaccine Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America DA2PP (DHPP) Vaccine Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa DA2PP (DHPP) Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa DA2PP (DHPP) Vaccine Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa DA2PP (DHPP) Vaccine Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa DA2PP (DHPP) Vaccine Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa DA2PP (DHPP) Vaccine Revenue by Country (US$ Million), 2027–2032
Table 50. Global DA2PP (DHPP) Vaccine Sales (K Units) by Type (2021–2026)
Table 51. Global DA2PP (DHPP) Vaccine Sales (K Units) by Type (2027–2032)
Table 52. Global DA2PP (DHPP) Vaccine Sales Market Share by Type (2021–2026)
Table 53. Global DA2PP (DHPP) Vaccine Sales Market Share by Type (2027–2032)
Table 54. Global DA2PP (DHPP) Vaccine Revenue (US$ Million) by Type (2021–2026)
Table 55. Global DA2PP (DHPP) Vaccine Revenue (US$ Million) by Type (2027–2032)
Table 56. Global DA2PP (DHPP) Vaccine Revenue Market Share by Type (2021–2026)
Table 57. Global DA2PP (DHPP) Vaccine Revenue Market Share by Type (2027–2032)
Table 58. Global DA2PP (DHPP) Vaccine Price (US$/Unit) by Type (2021–2026)
Table 59. Global DA2PP (DHPP) Vaccine Price (US$/Unit) by Type (2027–2032)
Table 60. Global DA2PP (DHPP) Vaccine Sales (K Units) by Application (2021–2026)
Table 61. Global DA2PP (DHPP) Vaccine Sales (K Units) by Application (2027–2032)
Table 62. Global DA2PP (DHPP) Vaccine Sales Market Share by Application (2021–2026)
Table 63. Global DA2PP (DHPP) Vaccine Sales Market Share by Application (2027–2032)
Table 64. Global DA2PP (DHPP) Vaccine Revenue (US$ Million) by Application (2021–2026)
Table 65. Global DA2PP (DHPP) Vaccine Revenue (US$ Million) by Application (2027–2032)
Table 66. Global DA2PP (DHPP) Vaccine Revenue Market Share by Application (2021–2026)
Table 67. Global DA2PP (DHPP) Vaccine Revenue Market Share by Application (2027–2032)
Table 68. Global DA2PP (DHPP) Vaccine Price (US$/Unit) by Application (2021–2026)
Table 69. Global DA2PP (DHPP) Vaccine Price (US$/Unit) by Application (2027–2032)
Table 70. Zoetis Company Information
Table 71. Zoetis Description and Business Overview
Table 72. Zoetis DA2PP (DHPP) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Zoetis DA2PP (DHPP) Vaccine Product
Table 74. Zoetis Recent Developments/Updates
Table 75. Merck Animal Health Company Information
Table 76. Merck Animal Health Description and Business Overview
Table 77. Merck Animal Health DA2PP (DHPP) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Merck Animal Health DA2PP (DHPP) Vaccine Product
Table 79. Merck Animal Health Recent Developments/Updates
Table 80. Pfizer Company Information
Table 81. Pfizer Description and Business Overview
Table 82. Pfizer DA2PP (DHPP) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Pfizer DA2PP (DHPP) Vaccine Product
Table 84. Pfizer Recent Developments/Updates
Table 85. Boehringer Ingelheim Company Information
Table 86. Boehringer Ingelheim Description and Business Overview
Table 87. Boehringer Ingelheim DA2PP (DHPP) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Boehringer Ingelheim DA2PP (DHPP) Vaccine Product
Table 89. Boehringer Ingelheim Recent Developments/Updates
Table 90. Virbac Company Information
Table 91. Virbac Description and Business Overview
Table 92. Virbac DA2PP (DHPP) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Virbac DA2PP (DHPP) Vaccine Product
Table 94. Virbac Recent Developments/Updates
Table 95. Durvet Company Information
Table 96. Durvet Description and Business Overview
Table 97. Durvet DA2PP (DHPP) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Durvet DA2PP (DHPP) Vaccine Product
Table 99. Durvet Recent Developments/Updates
Table 100. Elanco Company Information
Table 101. Elanco Description and Business Overview
Table 102. Elanco DA2PP (DHPP) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Elanco DA2PP (DHPP) Vaccine Product
Table 104. Elanco Recent Developments/Updates
Table 105. RuiPu Bio-Technology Company Information
Table 106. RuiPu Bio-Technology Description and Business Overview
Table 107. RuiPu Bio-Technology DA2PP (DHPP) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. RuiPu Bio-Technology DA2PP (DHPP) Vaccine Product
Table 109. RuiPu Bio-Technology Recent Developments/Updates
Table 110. CAHIC Company Information
Table 111. CAHIC Description and Business Overview
Table 112. CAHIC DA2PP (DHPP) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. CAHIC DA2PP (DHPP) Vaccine Product
Table 114. CAHIC Recent Developments/Updates
Table 115. Wuhan Keqian Biology Company Information
Table 116. Wuhan Keqian Biology Description and Business Overview
Table 117. Wuhan Keqian Biology DA2PP (DHPP) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Wuhan Keqian Biology DA2PP (DHPP) Vaccine Product
Table 119. Wuhan Keqian Biology Recent Developments/Updates
Table 120. Jilin Five-Star Animal Health Company Information
Table 121. Jilin Five-Star Animal Health Description and Business Overview
Table 122. Jilin Five-Star Animal Health DA2PP (DHPP) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. Jilin Five-Star Animal Health DA2PP (DHPP) Vaccine Product
Table 124. Jilin Five-Star Animal Health Recent Developments/Updates
Table 125. NeoTech Company Information
Table 126. NeoTech Description and Business Overview
Table 127. NeoTech DA2PP (DHPP) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 128. NeoTech DA2PP (DHPP) Vaccine Product
Table 129. NeoTech Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. DA2PP (DHPP) Vaccine Distributors List
Table 133. DA2PP (DHPP) Vaccine Customers List
Table 134. DA2PP (DHPP) Vaccine Market Trends
Table 135. DA2PP (DHPP) Vaccine Market Drivers
Table 136. DA2PP (DHPP) Vaccine Market Challenges
Table 137. DA2PP (DHPP) Vaccine Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
Table 141. Authors List of This Report
List of Figures
Figure 1. Product Picture of DA2PP (DHPP) Vaccine
Figure 2. Global DA2PP (DHPP) Vaccine Market Value by Type (US$ Million), 2021–2032
Figure 3. Global DA2PP (DHPP) Vaccine Market Share by Type: 2025 & 2032
Figure 4. Inactivated Vaccines Product Picture
Figure 5. Live Attenuated Vaccines Product Picture
Figure 6. Global DA2PP (DHPP) Vaccine Market Value by Application (US$ Million), 2021–2032
Figure 7. Global DA2PP (DHPP) Vaccine Market Share by Application: 2025 & 2032
Figure 8. Puppies
Figure 9. Adult Dogs
Figure 10. Global DA2PP (DHPP) Vaccine Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 11. Global DA2PP (DHPP) Vaccine Market Size (US$ Million), 2021–2032
Figure 12. Global DA2PP (DHPP) Vaccine Sales (K Units), 2021–2032
Figure 13. Global DA2PP (DHPP) Vaccine Average Price (US$/Unit), 2021–2032
Figure 14. DA2PP (DHPP) Vaccine Report Years Considered
Figure 15. DA2PP (DHPP) Vaccine Sales Share by Manufacturers in 2025
Figure 16. Global DA2PP (DHPP) Vaccine Revenue Share by Manufacturers in 2025
Figure 17. Top 5 and Top 10 Global DA2PP (DHPP) Vaccine Players: Market Share by Revenue in DA2PP (DHPP) Vaccine in 2025
Figure 18. DA2PP (DHPP) Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 19. Global DA2PP (DHPP) Vaccine Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 20. North America DA2PP (DHPP) Vaccine Sales Market Share by Country (2021–2032)
Figure 21. North America DA2PP (DHPP) Vaccine Revenue Market Share by Country (2021–2032)
Figure 22. United States DA2PP (DHPP) Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 23. Canada DA2PP (DHPP) Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Europe DA2PP (DHPP) Vaccine Sales Market Share by Country (2021–2032)
Figure 25. Europe DA2PP (DHPP) Vaccine Revenue Market Share by Country (2021–2032)
Figure 26. Germany DA2PP (DHPP) Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 27. France DA2PP (DHPP) Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. U.K. DA2PP (DHPP) Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. Italy DA2PP (DHPP) Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Russia DA2PP (DHPP) Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Asia Pacific DA2PP (DHPP) Vaccine Sales Market Share by Region (2021–2032)
Figure 32. Asia Pacific DA2PP (DHPP) Vaccine Revenue Market Share by Region (2021–2032)
Figure 33. China DA2PP (DHPP) Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Japan DA2PP (DHPP) Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. South Korea DA2PP (DHPP) Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. India DA2PP (DHPP) Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Australia DA2PP (DHPP) Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. China Taiwan DA2PP (DHPP) Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Southeast Asia DA2PP (DHPP) Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Latin America DA2PP (DHPP) Vaccine Sales Market Share by Country (2021–2032)
Figure 41. Latin America DA2PP (DHPP) Vaccine Revenue Market Share by Country (2021–2032)
Figure 42. Mexico DA2PP (DHPP) Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Brazil DA2PP (DHPP) Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Argentina DA2PP (DHPP) Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Colombia DA2PP (DHPP) Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Middle East and Africa DA2PP (DHPP) Vaccine Sales Market Share by Country (2021–2032)
Figure 47. Middle East and Africa DA2PP (DHPP) Vaccine Revenue Market Share by Country (2021–2032)
Figure 48. Turkey DA2PP (DHPP) Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Saudi Arabia DA2PP (DHPP) Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. UAE DA2PP (DHPP) Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Global Sales Market Share of DA2PP (DHPP) Vaccine by Type (2021–2032)
Figure 52. Global Revenue Market Share of DA2PP (DHPP) Vaccine by Type (2021–2032)
Figure 53. Global DA2PP (DHPP) Vaccine Price (US$/Unit) by Type (2021–2032)
Figure 54. Global Sales Market Share of DA2PP (DHPP) Vaccine by Application (2021–2032)
Figure 55. Global Revenue Market Share of DA2PP (DHPP) Vaccine by Application (2021–2032)
Figure 56. Global DA2PP (DHPP) Vaccine Price (US$/Unit) by Application (2021–2032)
Figure 57. DA2PP (DHPP) Vaccine Value Chain
Figure 58. Channels of Distribution (Direct Vs Distribution)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Table 1. Global DA2PP (DHPP) Vaccine Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global DA2PP (DHPP) Vaccine Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global DA2PP (DHPP) Vaccine Market Competitive Situation by Manufacturers in 2025
Table 4. Global DA2PP (DHPP) Vaccine Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global DA2PP (DHPP) Vaccine Sales Market Share by Manufacturers (2021–2026)
Table 6. Global DA2PP (DHPP) Vaccine Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global DA2PP (DHPP) Vaccine Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market DA2PP (DHPP) Vaccine Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of DA2PP (DHPP) Vaccine, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of DA2PP (DHPP) Vaccine, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of DA2PP (DHPP) Vaccine, Product Types and Applications
Table 12. Global Key Manufacturers of DA2PP (DHPP) Vaccine, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global DA2PP (DHPP) Vaccine Companies by Tier (Tier 1, Tier 2, Tier 3), based on DA2PP (DHPP) Vaccine Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global DA2PP (DHPP) Vaccine Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global DA2PP (DHPP) Vaccine Sales by Region (K Units), 2021–2026
Table 18. Global DA2PP (DHPP) Vaccine Sales Market Share by Region (2021–2026)
Table 19. Global DA2PP (DHPP) Vaccine Sales by Region (K Units), 2027–2032
Table 20. Global DA2PP (DHPP) Vaccine Sales Market Share by Region (2027–2032)
Table 21. Global DA2PP (DHPP) Vaccine Revenue by Region (US$ Million), 2021–2026
Table 22. Global DA2PP (DHPP) Vaccine Revenue Market Share by Region (2021–2026)
Table 23. Global DA2PP (DHPP) Vaccine Revenue by Region (US$ Million), 2027–2032
Table 24. Global DA2PP (DHPP) Vaccine Revenue Market Share by Region (2027–2032)
Table 25. North America DA2PP (DHPP) Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America DA2PP (DHPP) Vaccine Sales by Country (K Units), 2021–2026
Table 27. North America DA2PP (DHPP) Vaccine Sales by Country (K Units), 2027–2032
Table 28. North America DA2PP (DHPP) Vaccine Revenue by Country (US$ Million), 2021–2026
Table 29. North America DA2PP (DHPP) Vaccine Revenue by Country (US$ Million), 2027–2032
Table 30. Europe DA2PP (DHPP) Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe DA2PP (DHPP) Vaccine Sales by Country (K Units), 2021–2026
Table 32. Europe DA2PP (DHPP) Vaccine Sales by Country (K Units), 2027–2032
Table 33. Europe DA2PP (DHPP) Vaccine Revenue by Country (US$ Million), 2021–2026
Table 34. Europe DA2PP (DHPP) Vaccine Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific DA2PP (DHPP) Vaccine Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific DA2PP (DHPP) Vaccine Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific DA2PP (DHPP) Vaccine Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific DA2PP (DHPP) Vaccine Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific DA2PP (DHPP) Vaccine Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America DA2PP (DHPP) Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America DA2PP (DHPP) Vaccine Sales by Country (K Units), 2021–2026
Table 42. Latin America DA2PP (DHPP) Vaccine Sales by Country (K Units), 2027–2032
Table 43. Latin America DA2PP (DHPP) Vaccine Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America DA2PP (DHPP) Vaccine Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa DA2PP (DHPP) Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa DA2PP (DHPP) Vaccine Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa DA2PP (DHPP) Vaccine Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa DA2PP (DHPP) Vaccine Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa DA2PP (DHPP) Vaccine Revenue by Country (US$ Million), 2027–2032
Table 50. Global DA2PP (DHPP) Vaccine Sales (K Units) by Type (2021–2026)
Table 51. Global DA2PP (DHPP) Vaccine Sales (K Units) by Type (2027–2032)
Table 52. Global DA2PP (DHPP) Vaccine Sales Market Share by Type (2021–2026)
Table 53. Global DA2PP (DHPP) Vaccine Sales Market Share by Type (2027–2032)
Table 54. Global DA2PP (DHPP) Vaccine Revenue (US$ Million) by Type (2021–2026)
Table 55. Global DA2PP (DHPP) Vaccine Revenue (US$ Million) by Type (2027–2032)
Table 56. Global DA2PP (DHPP) Vaccine Revenue Market Share by Type (2021–2026)
Table 57. Global DA2PP (DHPP) Vaccine Revenue Market Share by Type (2027–2032)
Table 58. Global DA2PP (DHPP) Vaccine Price (US$/Unit) by Type (2021–2026)
Table 59. Global DA2PP (DHPP) Vaccine Price (US$/Unit) by Type (2027–2032)
Table 60. Global DA2PP (DHPP) Vaccine Sales (K Units) by Application (2021–2026)
Table 61. Global DA2PP (DHPP) Vaccine Sales (K Units) by Application (2027–2032)
Table 62. Global DA2PP (DHPP) Vaccine Sales Market Share by Application (2021–2026)
Table 63. Global DA2PP (DHPP) Vaccine Sales Market Share by Application (2027–2032)
Table 64. Global DA2PP (DHPP) Vaccine Revenue (US$ Million) by Application (2021–2026)
Table 65. Global DA2PP (DHPP) Vaccine Revenue (US$ Million) by Application (2027–2032)
Table 66. Global DA2PP (DHPP) Vaccine Revenue Market Share by Application (2021–2026)
Table 67. Global DA2PP (DHPP) Vaccine Revenue Market Share by Application (2027–2032)
Table 68. Global DA2PP (DHPP) Vaccine Price (US$/Unit) by Application (2021–2026)
Table 69. Global DA2PP (DHPP) Vaccine Price (US$/Unit) by Application (2027–2032)
Table 70. Zoetis Company Information
Table 71. Zoetis Description and Business Overview
Table 72. Zoetis DA2PP (DHPP) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Zoetis DA2PP (DHPP) Vaccine Product
Table 74. Zoetis Recent Developments/Updates
Table 75. Merck Animal Health Company Information
Table 76. Merck Animal Health Description and Business Overview
Table 77. Merck Animal Health DA2PP (DHPP) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Merck Animal Health DA2PP (DHPP) Vaccine Product
Table 79. Merck Animal Health Recent Developments/Updates
Table 80. Pfizer Company Information
Table 81. Pfizer Description and Business Overview
Table 82. Pfizer DA2PP (DHPP) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Pfizer DA2PP (DHPP) Vaccine Product
Table 84. Pfizer Recent Developments/Updates
Table 85. Boehringer Ingelheim Company Information
Table 86. Boehringer Ingelheim Description and Business Overview
Table 87. Boehringer Ingelheim DA2PP (DHPP) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Boehringer Ingelheim DA2PP (DHPP) Vaccine Product
Table 89. Boehringer Ingelheim Recent Developments/Updates
Table 90. Virbac Company Information
Table 91. Virbac Description and Business Overview
Table 92. Virbac DA2PP (DHPP) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Virbac DA2PP (DHPP) Vaccine Product
Table 94. Virbac Recent Developments/Updates
Table 95. Durvet Company Information
Table 96. Durvet Description and Business Overview
Table 97. Durvet DA2PP (DHPP) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Durvet DA2PP (DHPP) Vaccine Product
Table 99. Durvet Recent Developments/Updates
Table 100. Elanco Company Information
Table 101. Elanco Description and Business Overview
Table 102. Elanco DA2PP (DHPP) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Elanco DA2PP (DHPP) Vaccine Product
Table 104. Elanco Recent Developments/Updates
Table 105. RuiPu Bio-Technology Company Information
Table 106. RuiPu Bio-Technology Description and Business Overview
Table 107. RuiPu Bio-Technology DA2PP (DHPP) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. RuiPu Bio-Technology DA2PP (DHPP) Vaccine Product
Table 109. RuiPu Bio-Technology Recent Developments/Updates
Table 110. CAHIC Company Information
Table 111. CAHIC Description and Business Overview
Table 112. CAHIC DA2PP (DHPP) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. CAHIC DA2PP (DHPP) Vaccine Product
Table 114. CAHIC Recent Developments/Updates
Table 115. Wuhan Keqian Biology Company Information
Table 116. Wuhan Keqian Biology Description and Business Overview
Table 117. Wuhan Keqian Biology DA2PP (DHPP) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Wuhan Keqian Biology DA2PP (DHPP) Vaccine Product
Table 119. Wuhan Keqian Biology Recent Developments/Updates
Table 120. Jilin Five-Star Animal Health Company Information
Table 121. Jilin Five-Star Animal Health Description and Business Overview
Table 122. Jilin Five-Star Animal Health DA2PP (DHPP) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. Jilin Five-Star Animal Health DA2PP (DHPP) Vaccine Product
Table 124. Jilin Five-Star Animal Health Recent Developments/Updates
Table 125. NeoTech Company Information
Table 126. NeoTech Description and Business Overview
Table 127. NeoTech DA2PP (DHPP) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 128. NeoTech DA2PP (DHPP) Vaccine Product
Table 129. NeoTech Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. DA2PP (DHPP) Vaccine Distributors List
Table 133. DA2PP (DHPP) Vaccine Customers List
Table 134. DA2PP (DHPP) Vaccine Market Trends
Table 135. DA2PP (DHPP) Vaccine Market Drivers
Table 136. DA2PP (DHPP) Vaccine Market Challenges
Table 137. DA2PP (DHPP) Vaccine Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
Table 141. Authors List of This Report
List of Figures
Figure 1. Product Picture of DA2PP (DHPP) Vaccine
Figure 2. Global DA2PP (DHPP) Vaccine Market Value by Type (US$ Million), 2021–2032
Figure 3. Global DA2PP (DHPP) Vaccine Market Share by Type: 2025 & 2032
Figure 4. Inactivated Vaccines Product Picture
Figure 5. Live Attenuated Vaccines Product Picture
Figure 6. Global DA2PP (DHPP) Vaccine Market Value by Application (US$ Million), 2021–2032
Figure 7. Global DA2PP (DHPP) Vaccine Market Share by Application: 2025 & 2032
Figure 8. Puppies
Figure 9. Adult Dogs
Figure 10. Global DA2PP (DHPP) Vaccine Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 11. Global DA2PP (DHPP) Vaccine Market Size (US$ Million), 2021–2032
Figure 12. Global DA2PP (DHPP) Vaccine Sales (K Units), 2021–2032
Figure 13. Global DA2PP (DHPP) Vaccine Average Price (US$/Unit), 2021–2032
Figure 14. DA2PP (DHPP) Vaccine Report Years Considered
Figure 15. DA2PP (DHPP) Vaccine Sales Share by Manufacturers in 2025
Figure 16. Global DA2PP (DHPP) Vaccine Revenue Share by Manufacturers in 2025
Figure 17. Top 5 and Top 10 Global DA2PP (DHPP) Vaccine Players: Market Share by Revenue in DA2PP (DHPP) Vaccine in 2025
Figure 18. DA2PP (DHPP) Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 19. Global DA2PP (DHPP) Vaccine Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 20. North America DA2PP (DHPP) Vaccine Sales Market Share by Country (2021–2032)
Figure 21. North America DA2PP (DHPP) Vaccine Revenue Market Share by Country (2021–2032)
Figure 22. United States DA2PP (DHPP) Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 23. Canada DA2PP (DHPP) Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Europe DA2PP (DHPP) Vaccine Sales Market Share by Country (2021–2032)
Figure 25. Europe DA2PP (DHPP) Vaccine Revenue Market Share by Country (2021–2032)
Figure 26. Germany DA2PP (DHPP) Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 27. France DA2PP (DHPP) Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. U.K. DA2PP (DHPP) Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. Italy DA2PP (DHPP) Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Russia DA2PP (DHPP) Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Asia Pacific DA2PP (DHPP) Vaccine Sales Market Share by Region (2021–2032)
Figure 32. Asia Pacific DA2PP (DHPP) Vaccine Revenue Market Share by Region (2021–2032)
Figure 33. China DA2PP (DHPP) Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Japan DA2PP (DHPP) Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. South Korea DA2PP (DHPP) Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. India DA2PP (DHPP) Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Australia DA2PP (DHPP) Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. China Taiwan DA2PP (DHPP) Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Southeast Asia DA2PP (DHPP) Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Latin America DA2PP (DHPP) Vaccine Sales Market Share by Country (2021–2032)
Figure 41. Latin America DA2PP (DHPP) Vaccine Revenue Market Share by Country (2021–2032)
Figure 42. Mexico DA2PP (DHPP) Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Brazil DA2PP (DHPP) Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Argentina DA2PP (DHPP) Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Colombia DA2PP (DHPP) Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Middle East and Africa DA2PP (DHPP) Vaccine Sales Market Share by Country (2021–2032)
Figure 47. Middle East and Africa DA2PP (DHPP) Vaccine Revenue Market Share by Country (2021–2032)
Figure 48. Turkey DA2PP (DHPP) Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Saudi Arabia DA2PP (DHPP) Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. UAE DA2PP (DHPP) Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Global Sales Market Share of DA2PP (DHPP) Vaccine by Type (2021–2032)
Figure 52. Global Revenue Market Share of DA2PP (DHPP) Vaccine by Type (2021–2032)
Figure 53. Global DA2PP (DHPP) Vaccine Price (US$/Unit) by Type (2021–2032)
Figure 54. Global Sales Market Share of DA2PP (DHPP) Vaccine by Application (2021–2032)
Figure 55. Global Revenue Market Share of DA2PP (DHPP) Vaccine by Application (2021–2032)
Figure 56. Global DA2PP (DHPP) Vaccine Price (US$/Unit) by Application (2021–2032)
Figure 57. DA2PP (DHPP) Vaccine Value Chain
Figure 58. Channels of Distribution (Direct Vs Distribution)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Sales Planning Tool Market Research Report 2026
Feb 03, 26
Global Chromium Oxide Powder Market Research Report 2026
Feb 03, 26
Global Shape Memory Actuator Market Research Report 2026
Feb 03, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232